ACRV · Acrivon Therapeutics, Inc. · Documents
Market Cap
$76.74M
Shares
42.85M
Volume · Oct 20
185.41K
Avg daily vol (3M)
316.74K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2024-01-08 | — | |
| 8-K | — | 2023-12-08 | 2023-12-04 | |
| S-3 | — | 2023-12-01 | — | |
| 10-Q | — | 2023-11-09 | 2023-09-30 | |
| 8-K | — | 2023-11-09 | — | |
| 8-K | — | 2023-09-05 | — | |
| 8-K | — | 2023-08-11 | — | |
| 10-Q | — | 2023-08-11 | 2023-06-30 | |
| 8-K | — | 2023-06-22 | — | |
| 8-K | — | 2023-06-05 | 2023-05-30 | |
| DEFR14A | — | 2023-05-30 | — | |
| 8-K | — | 2023-05-09 | — | |
| 10-Q | — | 2023-05-09 | 2023-03-31 | |
| ARS | — | 2023-05-01 | 2022-12-31 | |
| 8-K | — | 2023-05-01 | — | |
| 8-K | — | 2023-05-01 | — | |
| DEFA14A | — | 2023-05-01 | — | |
| DEF 14A | — | 2023-05-01 | 2023-06-22 | |
| 8-K | — | 2023-04-25 | — | |
| 8-K | — | 2023-03-28 | — | |
| 10-K | — | 2023-03-28 | 2022-12-31 | |
| 8-K | — | 2023-03-13 | — | |
| 8-K | — | 2023-03-03 | — | |
| 10-Q | — | 2022-12-15 | 2022-09-30 | |
| 8-K | — | 2022-11-17 | 2022-11-14 | |
| S-1/A | — | 2022-11-08 | — | |
| S-1/A | — | 2022-11-03 | — | |
| S-1 | — | 2022-10-17 | — |
Showing 51–78 of 78 filings